Publications (original articles or review articles) published in 2012 from OUS - Department of Infectious Diseases

20 publications found

Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F (2012)
Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
Stat Med, 32 (8), 1407-18
DOI 10.1002/sim.5636, PubMed 23027651

Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419

Bugge HF, Karlsen NC, Oydna E, Rake MM, Wexels N, Bendabenda J, Roald B, Heier HE, Chisuwo L, Jourdan PM (2012)
A study of blood transfusion services at a district hospital in Malawi
Vox Sang, 104 (1), 37-45
DOI 10.1111/j.1423-0410.2012.01628.x, PubMed 22765350

Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592

De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
Infect Control Hosp Epidemiol, 33 (10), 1008-16
DOI 10.1086/667729, PubMed 22961020

Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Askling HH, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, O'Connor FS, Weld L, Parola P, EuroTravNet Network (2012)
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Eurosurveillance, 17 (26), 20205-26

Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Hervius Askling H, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, Santos O'Connor F, Weld L, Parola P, EuroTravNet Network (2012)
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Euro Surveill, 17 (26)
PubMed 22790534

Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
Exp Cell Res, 318 (14), 1611-9
DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621

Kjetland EF, Leutscher PD, Ndhlovu PD (2012)
A review of female genital schistosomiasis
Trends Parasitol, 28 (2), 58-65
DOI 10.1016/j.pt.2011.10.008, PubMed 22245065

Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485

Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
Arch Intern Med, 172 (16), 1252-5
DOI 10.1001/archinternmed.2012.2719, PubMed 22826124

Manner IW, Baekken M, Oektedalen O, Os I (2012)
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Blood Press, 21 (5), 311-9
DOI 10.3109/08037051.2012.680742, PubMed 22564000

Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
J Clin Hypertens (Greenwich), 15 (2), 101-6
DOI 10.1111/jch.12029, PubMed 23339727

Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
Int J Microbiol, 2012, 263836
DOI 10.1155/2012/263836, PubMed 22719767

Nowak P, Nystrom J, Troseid M (2012)
High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
Anticancer Res, 32 (9), 4067-9
PubMed 22993362

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017

Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672

Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
AAPS J, 15 (2), 308-15
DOI 10.1208/s12248-012-9440-8, PubMed 23224752

Scott JD, Dessauer CW, Taskén K (2012)
Creating order from chaos: cellular regulation by kinase anchoring
Annu Rev Pharmacol Toxicol, 53, 187-210
DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438

Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967

Publications (original articles or review articles) published in 2012 from OUS - Department of Infectious Diseases

20 publications found

Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F (2012)
Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
Stat Med, 32 (8), 1407-18
DOI 10.1002/sim.5636, PubMed 23027651

Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419

Bugge HF, Karlsen NC, Oydna E, Rake MM, Wexels N, Bendabenda J, Roald B, Heier HE, Chisuwo L, Jourdan PM (2012)
A study of blood transfusion services at a district hospital in Malawi
Vox Sang, 104 (1), 37-45
DOI 10.1111/j.1423-0410.2012.01628.x, PubMed 22765350

Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592

De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
Infect Control Hosp Epidemiol, 33 (10), 1008-16
DOI 10.1086/667729, PubMed 22961020

Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Askling HH, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, O'Connor FS, Weld L, Parola P, EuroTravNet Network (2012)
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Eurosurveillance, 17 (26), 20205-26

Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Hervius Askling H, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, Santos O'Connor F, Weld L, Parola P, EuroTravNet Network (2012)
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Euro Surveill, 17 (26)
PubMed 22790534

Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
Exp Cell Res, 318 (14), 1611-9
DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621

Kjetland EF, Leutscher PD, Ndhlovu PD (2012)
A review of female genital schistosomiasis
Trends Parasitol, 28 (2), 58-65
DOI 10.1016/j.pt.2011.10.008, PubMed 22245065

Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485

Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
Arch Intern Med, 172 (16), 1252-5
DOI 10.1001/archinternmed.2012.2719, PubMed 22826124

Manner IW, Baekken M, Oektedalen O, Os I (2012)
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Blood Press, 21 (5), 311-9
DOI 10.3109/08037051.2012.680742, PubMed 22564000

Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
J Clin Hypertens (Greenwich), 15 (2), 101-6
DOI 10.1111/jch.12029, PubMed 23339727

Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
Int J Microbiol, 2012, 263836
DOI 10.1155/2012/263836, PubMed 22719767

Nowak P, Nystrom J, Troseid M (2012)
High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
Anticancer Res, 32 (9), 4067-9
PubMed 22993362

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017

Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672

Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
AAPS J, 15 (2), 308-15
DOI 10.1208/s12248-012-9440-8, PubMed 23224752

Scott JD, Dessauer CW, Taskén K (2012)
Creating order from chaos: cellular regulation by kinase anchoring
Annu Rev Pharmacol Toxicol, 53, 187-210
DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438

Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967